Skip to main content
SpringerLink
Log in

Editor’s note

Alzheimer’s disease: My point of view

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aronov S., Aranda G., Behar L., and Ginzburg I. (2001) Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal. J. Neurosci. 21, 6577–6587.

    PubMed  CAS  Google Scholar 

  • Bassan M., Zamostiano R., Davidson A., et al. (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283–1293.

    Article  PubMed  CAS  Google Scholar 

  • Beni-Adani L., Gozes I., Cohen Y., et al. (2001) A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57–63.

    PubMed  CAS  Google Scholar 

  • Bowirrat, A., Friedland, R. P., Chapman, J., and Korczyn, A. D. (2000) The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. Neurology 55, 731.

    PubMed  CAS  Google Scholar 

  • Chen Y., Lomnitski L., Michaelson D. M., and Shohami E. (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80, 1255–1262.

    Article  PubMed  CAS  Google Scholar 

  • Fisher A., Brandeis R., Haring R., et al. (1998) Novel ml muscarinic agonists in treatment and delaying the progression of Alzheimer’s disease: a unifying hypothesis. J. Physiol. Paris 92, 337–340.

    Article  PubMed  CAS  Google Scholar 

  • Frenkel D., Kariv N., and Solomon B. (2001) Generation of auto-antibodies towards Alzheimer’s disease vaccination. Vaccine 19, 2615–2619.

    Article  PubMed  CAS  Google Scholar 

  • Gilgun-Sherki Y., Melamed E., and Offen D. (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959–975.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I. And Brenneman D. E. (2000a) A new concept in the pharmacology of neuroprotection. J. Mol. Neurosci. 14, 61–68.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Giladi E., Pinhasov A., Bardea A. and Brennaman D. E. (2000b) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J. Pharmacol. Exp. Ther. 293, 1091–1098.

    PubMed  CAS  Google Scholar 

  • Gozes I. (2001) Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends in Neurosci. In Press.

  • Levy-Lahad, E. and Bird T. D. (1996) Genetic factors in Alzheimer’s disease: a review of recent advances. Ann. Neurol. 40, 829–840.

    Article  PubMed  CAS  Google Scholar 

  • Offen D., Sherki Y., Melamed E., Fridkin M., Brennaman D.E. and Gozes I. (2000) Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson’s disease. Brain Res. 854, 257–262.

    Article  PubMed  CAS  Google Scholar 

  • Soreq H. and Seidman S. (2001) Acetylcholinesterase—new roles for an old actor. Nat. Rev. Neurosci. 2, 294–302.

    Article  PubMed  CAS  Google Scholar 

  • Spong C. Y., Abebe, D. T., Gozes I., Brenneman D. E., and Hill J. M. (2001) Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 297, 774–779.

    PubMed  CAS  Google Scholar 

  • Steingart R. A., Solomon B., Brenneman D. E., Fridkin M., and Gozes I. (2000) VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 15, 137–145.

    Article  PubMed  CAS  Google Scholar 

  • Weinstock M., Bejar C., Wang R. H., et al. (2000) TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease. J. Neural. Transm. Suppl. 60, 157–169.

    PubMed  Google Scholar 

  • Zamostiano R., Pinhasov A., Gelber E., et al. (2001) Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276, 708–714.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978, Tel Aviv, Israel

    Illana Gozes

Authors
  1. Illana Gozes
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Support: ISOA, ISF, BSF, Neufeld Award, NIH, Gildor Chair.

Commercial entities that study Alzheimer’s research in Israel were not reviewed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gozes, I. Editor’s note. J Mol Neurosci 17, 269–270 (2001). https://doi.org/10.1385/JMN:17:2:269

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:17:2:269

Search

Navigation